Comments
Commented by Stefan Feulner on November 8th, 2022 | 11:18 CET
Barrick Gold, Manuka Resources, Newmont - Has the bottom been reached?
After the Federal Reserve once again raised the key interest rate with a big step of 0.75 points to a range of 3.75% to 4.00%, the pace is now likely to slow down step by step. In the process, voices are growing louder, calling for a departure from the strict monetary policy. In the course of this, precious metal prices reacted and distanced themselves significantly from their lows for the year. The signs are pointing to easing. At least in the short term, gold and silver should be ripe for a pronounced countermovement.
Read
Commented by André Will-Laudien on November 8th, 2022 | 10:15 CET
Varta, Kleos Space, ThyssenKrupp: Wrongly valued? It cannot be!
What a wild ride! The US technology exchange NASDAQ fell by a full 33% in the last 12 months, while the German standard share index DAX fell by only 16%. That is astonishing because the leading German index usually reacts disproportionately to the US growth stocks. Ultimately, however, it is becoming clear that foreigners dominate German share prices. After all, if the euro's currency losses are considered, both indices are back on par. The euro has, after all, also depreciated by 15% since a year ago. Some high-tech stocks in Germany lost significantly more than average. We take a closer look.
Read
Commented by Nico Popp on November 7th, 2022 | 13:12 CET
The revolution for the portfolio: Meta Platforms, Meta Materials, BYD
The ancient Greeks have always been popular with investors. On the one hand, key figures such as beta, gamma or theta make it clear how warrants behave; on the other hand, a look at the ancient Greeks allows for interesting word creations, for example, when it comes to new companies. The prefix "meta" describes either a change or a higher level. In this article, we highlight two companies that have used this Greek syllable. We explain which shares stand for revolutions and where investors should better steer clear of meta-levels.
Read
Commented by André Will-Laudien on November 7th, 2022 | 12:07 CET
Up or down? Stocks in sports mode: PayPal, Meta Platforms, Barsele Minerals, Porsche, VW
Today, a historical review takes us back to the period of the Weimar Republic from 1918 to 1933. After the end of the First World War, the government printed money to finance war bonds, jobs for returning soldiers and reparations to the victorious powers. As a result, the money supply increased permanently, prices rose faster and faster, and purchasing power declined. Raw materials for the domestic economy had to be purchased more and more expensively from abroad, but since there were no longer enough goods available, prices continued to rise explosively. From 1922 onward, the talk was no longer of creeping inflation but of galloping inflation. Today, 100 years later, the German producer price index rose by over 45.8% in September. What do investors need to watch out for now?
Read
Commented by Armin Schulz on November 7th, 2022 | 10:31 CET
BioNTech, Cardiol Therapeutics, Bayer - Strong growth in the pharmaceutical industry over the coming years
Demographic change is bringing new customers to pharmaceutical and biotech companies. Worldwide, the population is getting older, and with it, the number of patients with dementia, cancer and heart disease. Experts estimate that the population over 65 will increase steadily until 2050. The 'pill gap' will start to have a real impact from 2030, and then the proportion of the aging population will rise again in proportion. Accordingly, all healthcare companies will see growth as the number of customers grows. So today, we look at three companies committed to better patient health.
Read
Commented by Nico Popp on November 3rd, 2022 | 13:05 CET
Fear is spreading: Volkswagen, Varta, Altech Advanced Materials
Consulting firms like Roland Berger see the automotive industry undergoing a "triple transformation." No wonder large automotive groups are doing everything possible to become fit for the future. In addition to model electrification, digitization and greater sustainability are also playing a role in the battle for tomorrow's customers. Over the next three minutes, we explain what role technical innovations play in this.
Read
Commented by Fabian Lorenz on November 3rd, 2022 | 12:01 CET
BioNTech, Moderna and Defence Therapeutics right in the middle of the billion-dollar mRNA market! And Bayer?
BioNTech and Moderna's mRNA-based vaccines have successfully contributed to the containment of the COVID-19 pandemic. This has helped the relatively new technology for developing vaccines and other drugs to make a breakthrough. According to Precedence Research market researchers, the mRNA therapeutics market is expected to exceed USD 128 billion by 2030. The average annual growth would be around 13%. German top dog BioNTech is betting heavily on vaccines to fight cancer, among other things. Defence Therapeutics is now also entering the billion-dollar market, continuing the positive newsflow of recent weeks. The Canadians are opening up their platform for mRNA research, and their valuation is anything but expensive. Bayer is also too cheap at the moment. Analysts at least see a good 50% price potential.
Read
Commented by Stefan Feulner on November 3rd, 2022 | 11:53 CET
TeamViewer, Tocvan Ventures, Advanced Micro Devices - High rebound opportunities
The reporting season for the third quarter is exhilarating. It can be seen that stocks, which in some cases suffered exaggerated price losses in recent months, are starting to jump in price simply because their forecasts have been confirmed. Something similar could also happen in the precious metals sector. Should the monetary authorities loosen the monetary policy again in the coming months, this should result in a rally in gold and silver mining stocks.
Read
Commented by Armin Schulz on November 2nd, 2022 | 14:10 CET
BioNTech, XPhyto Therapeutics, MorphoSys - Biotech stocks facing a renaissance?
While the Corona pandemic plunged many companies into crisis, the biotech sector was the big winner. The fastest vaccine developers raked in record profits and are still profiting from vaccine orders today. Meanwhile, the Corona Crisis is no longer the focus of attention in many parts of the world. This is one of the reasons why the NASDAQ Biotech Index suffered significant losses until the end of September. In some cases, the shares of biotechnology companies were trading below their cash levels. Since October, things have been on the upswing. Reason enough to take a look at three interesting biotech companies.
Read
Commented by André Will-Laudien on November 2nd, 2022 | 13:34 CET
GreenTech shares jump! Siemens Energy, Defense Metals, JinkoSolar, and Nordex in focus
Fossil energy supply is becoming increasingly expensive. The political disappearance of supplier and commodity giant Russia is creating a dangerous undersupply, especially for Central Europe. The approaching winter could pose problems, and the industry might have to deal with rationing in the medium term. Products are becoming considerably more expensive to produce, and as a result, selling prices on the shelves are also increasing. The inflationary spiral is thus spiraling upward, and sales are falling. Meanwhile, GreenTech solutions are more in demand than ever for the purchase of energy. Which shares are playing to the fore here?
Read